← Back to Screener
Genenta Science S.p.A. American Depositary Shares (GNTA)
Price$2.04
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)-6.43%
Price vs S&P 500 (4W)225.84%
VGM Score65.49
Market Capitalization$53.11M
All Metrics
Book Value / Share (Quarterly)$1.08
P/TBV (Annual)2.70x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.34
Price vs S&P 500 (YTD)28.75%
EPS (TTM)$-0.39
10-Day Avg Trading Volume8.36M
EPS Excl Extra (TTM)$-0.39
EPS (Annual)$-0.38
ROI (Annual)-22.18%
Cash / Share (Quarterly)$1.39
ROA (Last FY)-20.48%
EBITD / Share (TTM)$-0.39
ROE (5Y Avg)-39.94%
Cash Flow / Share (Annual)$-0.34
P/B Ratio1.82x
P/B Ratio (Quarterly)1.08x
Net Income / Employee (Annual)$-839,036
Net Interest Coverage (TTM)-552.00x
ROA (TTM)-24.44%
EPS Incl Extra (Annual)$-0.38
Current Ratio (Annual)14.16x
Quick Ratio (Quarterly)14.07x
3-Month Avg Trading Volume1.03M
52-Week Price Return-53.21%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.72
52-Week High$10.00
EPS Excl Extra (Annual)$-0.38
CapEx CAGR (5Y)-17.53%
26-Week Price Return1.49%
Quick Ratio (Annual)14.07x
13-Week Price Return124.94%
Total Debt / Equity (Annual)0.35x
Current Ratio (Quarterly)14.16x
Enterprise Value$48.49M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$1.39
3-Month Return Std Dev175.19%
Net Income / Employee (TTM)$-839,036
ROE (Last FY)-29.90%
Net Interest Coverage (Annual)-7.46x
EPS Basic Excl Extra (Annual)$-0.38
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)0.35x
EPS Incl Extra (TTM)$-0.39
Receivables Turnover (Annual)0.00x
ROI (TTM)-26.59%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$2.16
Price vs S&P 500 (52W)-77.58%
Year-to-Date Return36.91%
5-Day Price Return23.64%
EPS Normalized (Annual)$-0.38
ROA (5Y Avg)-34.38%
Month-to-Date Return98.06%
Cash Flow / Share (TTM)$-0.91
EBITD / Share (Annual)$-0.39
LT Debt / Equity (Annual)0.35x
ROI (5Y Avg)-38.39%
LT Debt / Equity (Quarterly)0.35x
EPS Basic Excl Extra (TTM)$-0.39
P/TBV (Quarterly)3.39x
P/B Ratio (Annual)1.08x
Book Value / Share (Annual)$1.08
Price vs S&P 500 (13W)116.69%
Beta0.67x
Revenue / Share (TTM)$0.00
ROE (TTM)-38.46%
52-Week Low$0.55
mGradeB
vgmGradeB
Show chart for
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.14
4.14
4.14
4.14
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
GNTAGenenta Science S.p.A. American Depositary Shares | — | — | B | $2.04 |
| AMGNAmgen Inc | C | C | C | $349.58 |
| GILDGilead Sciences Inc | C | B | C | $129.16 |
| ARGXargenx SE American Depositary Shares | D | A | B | $891.32 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $149.23 |
| BIIBBiogen Inc. Common Stock | B | D | B | $195.34 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.08 |
| MRNAModerna, Inc. Common Stock | C | B | B | $47.44 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $163.88 |
| EXELExelixis Inc | C | B | B | $52.70 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | A | $301.00 |
About
Genenta Science is a clinical-stage biotechnology company developing hematopoietic stem cell gene therapies for solid tumors. Its pipeline includes Temferon, a therapeutic candidate designed to treat glioblastoma multiforme, an aggressive form of brain cancer.